How can pharmacogenomics influence medication safety and dose optimization, and what are its limits?

• A. Replacing clinical monitoring
• B. Eliminates need for dose adjustments
• C. Being universally available and easy to interpret
• D. Identifies genetic variants affecting metabolism or response

Answer: (D)

Pharmacogenomics focuses on how genetic differences alter how a person metabolizes drugs and how their body responds to them. By identifying variants that affect metabolic enzymes or drug targets, clinicians can anticipate who will have higher or lower drug exposure, who may experience more or less effect, and who is at risk for adverse reactions. This allows dose optimization and safer therapy by guiding the choice of drug and the starting dose, with adjustments based on expected response.

But this approach has limits. Not all drugs have well-established genetic markers, and the evidence can vary by gene, drug, and population. Genetic testing isn’t universally available or easy to interpret in every clinical setting, and results must be integrated with other factors such as age, organ function, drug interactions, and comorbidities. Because many influences on drug response extend beyond genetics, pharmacogenomics complements—not replaces—clinical monitoring and traditional dose adjustments.